Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(2021) In British Journal of Cancer 125(8). p.1135-1145- Abstract
Background: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk. Methods: We applied Mendelian randomisation (MR) to evaluate a potential causal effect of cigarette smoking on breast cancer risk. Both individual-level data as well as summary statistics for 164 single-nucleotide polymorphisms (SNPs) reported in genome-wide association studies of lifetime smoking index (LSI) or cigarette per day (CPD) were used to obtain MR effect estimates. Data from 108,420 invasive breast cancer cases and 87,681 controls were used for the LSI analysis and for the CPD analysis conducted among ever-smokers... (More)
Background: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk. Methods: We applied Mendelian randomisation (MR) to evaluate a potential causal effect of cigarette smoking on breast cancer risk. Both individual-level data as well as summary statistics for 164 single-nucleotide polymorphisms (SNPs) reported in genome-wide association studies of lifetime smoking index (LSI) or cigarette per day (CPD) were used to obtain MR effect estimates. Data from 108,420 invasive breast cancer cases and 87,681 controls were used for the LSI analysis and for the CPD analysis conducted among ever-smokers from 26,147 cancer cases and 26,072 controls. Sensitivity analyses were conducted to address pleiotropy. Results: Genetically predicted LSI was associated with increased breast cancer risk (OR 1.18 per SD, 95% CI: 1.07–1.30, P = 0.11 × 10–2), but there was no evidence of association for genetically predicted CPD (OR 1.02, 95% CI: 0.78–1.19, P = 0.85). The sensitivity analyses yielded similar results and showed no strong evidence of pleiotropic effect. Conclusion: Our MR study provides supportive evidence for a potential causal association with breast cancer risk for lifetime smoking exposure but not cigarettes per day among smokers.
(Less)
- author
- author collaboration
- organization
- publishing date
- 2021-08-02
- type
- Contribution to journal
- publication status
- published
- subject
- in
- British Journal of Cancer
- volume
- 125
- issue
- 8
- pages
- 1135 - 1145
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:34341517
- scopus:85112658433
- ISSN
- 0007-0920
- DOI
- 10.1038/s41416-021-01432-8
- language
- English
- LU publication?
- yes
- id
- 165ea89a-90df-4c82-b9ff-ba909ab51e05
- date added to LUP
- 2021-09-23 15:32:34
- date last changed
- 2023-09-13 01:25:57
@article{165ea89a-90df-4c82-b9ff-ba909ab51e05, abstract = {{<p>Background: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk. Methods: We applied Mendelian randomisation (MR) to evaluate a potential causal effect of cigarette smoking on breast cancer risk. Both individual-level data as well as summary statistics for 164 single-nucleotide polymorphisms (SNPs) reported in genome-wide association studies of lifetime smoking index (LSI) or cigarette per day (CPD) were used to obtain MR effect estimates. Data from 108,420 invasive breast cancer cases and 87,681 controls were used for the LSI analysis and for the CPD analysis conducted among ever-smokers from 26,147 cancer cases and 26,072 controls. Sensitivity analyses were conducted to address pleiotropy. Results: Genetically predicted LSI was associated with increased breast cancer risk (OR 1.18 per SD, 95% CI: 1.07–1.30, P = 0.11 × 10<sup>–2</sup>), but there was no evidence of association for genetically predicted CPD (OR 1.02, 95% CI: 0.78–1.19, P = 0.85). The sensitivity analyses yielded similar results and showed no strong evidence of pleiotropic effect. Conclusion: Our MR study provides supportive evidence for a potential causal association with breast cancer risk for lifetime smoking exposure but not cigarettes per day among smokers.</p>}}, author = {{Park, Hanla A. and Neumeyer, Sonja and Michailidou, Kyriaki and Bolla, Manjeet K. and Wang, Qin and Dennis, Joe and Ahearn, Thomas U. and Andrulis, Irene L. and Anton-Culver, Hoda and Antonenkova, Natalia N. and Arndt, Volker and Aronson, Kristan J. and Augustinsson, Annelie and Baten, Adinda and Beane Freeman, Laura E. and Becher, Heiko and Beckmann, Matthias W. and Behrens, Sabine and Benitez, Javier and Bermisheva, Marina and Bogdanova, Natalia V. and Bojesen, Stig E. and Brauch, Hiltrud and Brenner, Hermann and Brucker, Sara Y. and Burwinkel, Barbara and Campa, Daniele and Canzian, Federico and Castelao, Jose E. and Chanock, Stephen J. and Chenevix-Trench, Georgia and Clarke, Christine L. and Børresen-Dale, Anne Lise and Grenaker Alnæs, Grethe I. and Sahlberg, Kristine K. and Ottestad, Lars and Kåresen, Rolf and Schlichting, Ellen and Holmen, Marit Muri and Sauer, Toril and Haakensen, Vilde and Engebråten, Olav and Naume, Bjørn and Fosså, Alexander and Kiserud, Cecile E. and Reinertsen, Kristin V. and Helland, Åslaug and Riis, Margit and Geisler, Jürgen and Olsson, Håkan}}, issn = {{0007-0920}}, language = {{eng}}, month = {{08}}, number = {{8}}, pages = {{1135--1145}}, publisher = {{Nature Publishing Group}}, series = {{British Journal of Cancer}}, title = {{Mendelian randomisation study of smoking exposure in relation to breast cancer risk}}, url = {{http://dx.doi.org/10.1038/s41416-021-01432-8}}, doi = {{10.1038/s41416-021-01432-8}}, volume = {{125}}, year = {{2021}}, }